Latest News
Read more news
-
Discontinuation of Genetic Testing for Chronic Idiopathic Pancreatitis 30 May 2025 Following a recent review, PathWest will discontinue genetic testing for chronic idiopathic pancreatitis (CIP) from 03 June 2025. This decision follows a clinical and operational review which identified: CIP testing is not supported by Medicare. Current CIP testing has limited clinical utility in comparison to the international benchmark: Low diagnostic yield of less than 10% compared to 20 to 30% (PMID: 39172977). Broader and more comprehensive hereditary pancreatitis testing is available internationally through other providers. These include: Canterbury Health Laboratories (NZ) – PRSS1, SPINK1, CFTR, CELA3B ARUP Laboratories (USA) – CFTR, CTRC, PRSS1, SPINK1 Prevention Genetics (USA) – CASR, CFTR, CPA1, CTRC, PRSS1, SPINK1, TRPV6 Blueprint Genetics (USA) – APOA5, APOC2, CFTR, CPA1, CTRC, GPIHBP1, PRSS1, SPINK1, UBR1 We ap... -
PathWest makes Australia’s top companies’ list for the midsize category 17 April 2025 PathWest is honoured to be named on LinkedIn’s 2025 Top Companies list in Australia for the midsize category – a prestigious recognition celebrating leading workplaces with fewer than 5,000 employees where professionals can thrive and grow their careers. PathWest is the only Western Australian entity to be named for 2025. "This recognition reflects our ongoing commitment to fostering a positive, inclusive, and empowering workplace where every team member feels supported and inspired to reach their full potential", said Dr Narelle Hadlow, PathWest Chief Executive. "Thank you to our incredible team for improving the health, wellbeing, and safety of our communities every day – this achievement is yours." Learn more -
Sendaway Testing for Neuronal Antibodies 13 March 2025 PathWest wishes to advise that the process for send away testing for neuronal antibodies require discussion with, and approval by, an immunopathologist. If the testing is thought to be clinically appropriate, and where relevant first tier testing is negative, testing will be organised and the costs covered by PathWest laboratory. For testing that is deemed to be required, but is discordant with the current accepted clinical syndrome, the cost will need to be covered by the requesting department. For all requests that are received, without prior discussion and approval, the sample will not be tested and will be stored. Requests from other private pathology services will not be sent away and any samples received will be returned. If you have any questions or need additional information/assistance, please contact the PathWest Immunology Laboratory and an immunopathologi... -
2024 Festive Season Opening Hours 17 December 2024 PathWest collection centres will be closed on the following dates: 2024 Wednesday 25 December Thursday 26 December Sunday 29 December. 2025 Wednesday 1 January. Collection centres that are normally closed on weekends will be closed as usual on Saturday 28 December 2024. Find your nearest collection centre. PathWest wishes you a safe and happy festive season! -
Recognition of Service Awards 2024 21 November 2024 On Wednesday, 20 November, PathWest recognised the significant contributions of staff who have served 20, 30, and 40 years in public pathology, acknowledging the dedication and expertise that have helped shape our organisation over the decades. The event commenced with a Welcome to Country by Mr Nigel Wilkes Snr. Both our Chief Executive, Dr Narelle Hadlow and Board Chair, Angie Paskevicius, delivered speeches, recognising the contributions of all award recipients, and highlighting the importance of their service to the organisation’s continued success. Our Executive Director People, Capability, and Culture, Jo McCran, reflected on how employment processes have evolved, sharing insights into what an employment letter looked like in 1984. This reflection provided context for the changes and progress made over the years in supporting our workforce. Attendees from across sites, celeb...
Last Updated:
20/05/2025